“Design, Synthesis, and In-silico Evaluation of Benzyl oxybenzoate Derivatives as Dual HDAC Inhibitors for Cancer and CNS Disorders” (2026) Al Mustansiriyah Journal of Pharmaceutical Sciences, 25(5), pp. 917–930. doi:10.32947/ajps.v25i5.1307.